AsianScientist (Sep. 3, 2012) – U.S.-based biotechnology company Life Technologies Corporation and Chinese biotech company Sino Biological Inc. have announced a partnership for worldwide product distribution and product development.
Under the agreement, Life Technologies will distribute Sino Biological’s large portfolio of recombinant proteins, antibodies, and ELISA kits using its global distribution channels.
The two companies will also jointly develop new proteomic products for additional applications including flow cytometry and imaging technologies.
“The collaboration presents a tremendous opportunity to offer a robust proteomics portfolio to meet customer needs in this highly dynamic global market,” said Gregory T. Lucier, Chairman and CEO of Life Technologies.
“Sino Biological’s mission is to develop the best quality biological tools to assist scientists,” said Dr. Liangzhi Xie, president and CEO of Sino Biological. “Combining our state-of-the-art, disruptive technologies in recombinant protein production and antibody development with Life Technologies’ innovative product development and worldwide marketing, will allow us to bring powerful research tools to scientists solving critical puzzles in life science research and drug discovery.”
——
Source: Life Technologies Corporation.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.
